Renal secretion of inactive renin and extraction of angiotensin II in renal artery stenosis in man: factors determining renal vein renin ratio. 1984

D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson

Triplicate blood samples were obtained, without stimulation, simultaneously from the aorta and both renal veins in 24 untreated hypertensive patients with unilateral renal artery stenosis. Across the affected kidney the plasma concentrations of active renin, inactive renin and angiotensin II increased by 363% (P less than 0.001), 80% (P less than 0.05) and 100% (P less than 0.05) respectively. Thus the affected kidney was secreting both active and inactive renin, while appreciable quantities of angiotensin II were generated across the renal circulation on that side. Across the contralateral unaffected kidney there were no significant changes in concentration of active or inactive renin, indicating net suppression of secretion of both forms of renin. Plasma angiotensin II concentration was however markedly reduced, to 50% of the arterial value (P less than 0.001), in the contralateral renal vein, demonstrating renal extraction of angiotensin II. In 14 patients renal plasma flow was also measured. The ratio of active renin concentration between the two renal veins correlated more closely with the renal plasma flow to the affected kidney (r = -0.81; P less than 0.01) than with renin secretion rate on that side (r = +0.37; NS). Thus reduction in renal blood flow rather than increase in renin secretion appeared to be the major determinant of renal vein renin ratio.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D012082 Renal Veins Short thick veins which return blood from the kidneys to the vena cava. Renal Vein,Vein, Renal,Veins, Renal
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
September 1972, Annals of internal medicine,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
May 1987, Kidney international. Supplement,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
January 1978, Contributions to nephrology,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
January 1977, Cardiovascular research,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
January 2015, Seminars in dialysis,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
December 1978, Clinical science and molecular medicine. Supplement,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
July 2014, Clinical journal of the American Society of Nephrology : CJASN,
D J Webb, and A M Cumming, and F C Adams, and G P Hodsman, and B J Leckie, and A F Lever, and J J Morton, and G D Murray, and J I Robertson
January 1987, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!